The Institute of Gastroenterology and Liver Disease

Tel Aviv, Israel

The Institute of Gastroenterology and Liver Disease

Tel Aviv, Israel

Time filter

Source Type

Mouler Rechtman M.,The Institute of Gastroenterology and Liver Disease | Har-Noy O.,The Institute of Gastroenterology and Liver Disease | Bar-Yishay I.,The Institute of Gastroenterology and Liver Disease | Fishman S.,The Institute of Gastroenterology and Liver Disease | And 4 more authors.
FEBS Letters | Year: 2010

Hepatitis B virus (HBV) infects the liver and uses its cell host for gene expression and propagation. Therefore, targeting host factors essential for HBV gene expression is a potential anti-viral strategy. Here we show that treating HBV expressing cells with the natural phenolic compound curcumin inhibits HBV gene expression and replication. This inhibition is mediated via down-regulation of PGC-1α, a starvation-induced protein that initiates the gluconeogenesis cascade and that has been shown to robustly coactivate HBV transcription. We suggest curcumin as a host targeted therapy for HBV infection that may complement current virus-specific therapies. © 2010 Federation of European Biochemical Societies.

Loading The Institute of Gastroenterology and Liver Disease collaborators
Loading The Institute of Gastroenterology and Liver Disease collaborators